Mutations, however, result in a constitutively active protein that continuously stimulates downstream signaling pathways, such as the MAPK and PI3K-AKT pathways, promoting uncontrolled growth of cancer cells [56,57]. The gene discussed is PIK3CG; the disease is cancer.